CREB1 and neoplasm: This increase in turn upregulates the expression of the lineage commitment transcription factor ASCL1 via the ERK/CREB signaling pathway, thereby promoting tumor progression and androgen receptor pathway inhibitor resistance (Tabrizian et al, 2023).